Sabra Healthcare REIT (NASDAQ:SBRA) Director Michael Foster Sells 10,000 Shares of Company Stock

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Director Michael Foster sold 10,000 shares of the stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $20.98, for a total transaction of $209,800.00. Following the sale, the director owned 72,834 shares of the company’s stock, valued at approximately $1,528,057.32. This represents a 12.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Sabra Healthcare REIT Trading Down 2.0%

Shares of Sabra Healthcare REIT stock opened at $20.56 on Friday. Sabra Healthcare REIT, Inc. has a 1 year low of $17.53 and a 1 year high of $22.77. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.21 and a current ratio of 1.21. The company has a market capitalization of $5.39 billion, a P/E ratio of 73.43, a PEG ratio of 1.83 and a beta of 0.68. The company’s fifty day moving average is $19.89 and its two-hundred day moving average is $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.05). Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.55%. The business had revenue of $249.57 million during the quarter, compared to analyst estimates of $236.64 million. During the same quarter in the prior year, the firm posted $0.38 earnings per share. The company’s revenue for the quarter was up 31.4% compared to the same quarter last year. Analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 428.57%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on SBRA shares. Robert W. Baird increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Monday, August 31st. UBS Group boosted their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Wednesday. Citizens Jmp upped their price target on Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a research note on Wednesday, July 22nd. Raymond James Financial raised Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. Finally, Weiss Ratings raised Sabra Healthcare REIT from a “hold (c)” rating to a “buy (b-)” rating in a report on Tuesday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $21.67.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of hedge funds have recently added to or reduced their stakes in the company. Global Retirement Partners LLC increased its position in Sabra Healthcare REIT by 7.7% during the 3rd quarter. Global Retirement Partners LLC now owns 7,080 shares of the real estate investment trust’s stock worth $140,000 after purchasing an additional 505 shares during the period. Nissay Asset Management Corp Japan raised its stake in shares of Sabra Healthcare REIT by 1.5% during the 2nd quarter. Nissay Asset Management Corp Japan now owns 38,957 shares of the real estate investment trust’s stock worth $760,000 after buying an additional 585 shares in the last quarter. Versant Capital Management Inc raised its stake in shares of Sabra Healthcare REIT by 70.0% during the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after buying an additional 603 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Sabra Healthcare REIT by 7.9% during the 3rd quarter. GAMMA Investing LLC now owns 9,927 shares of the real estate investment trust’s stock worth $196,000 after buying an additional 724 shares in the last quarter. Finally, Anchor Investment Management LLC lifted its holdings in shares of Sabra Healthcare REIT by 17.8% in the 2nd quarter. Anchor Investment Management LLC now owns 4,877 shares of the real estate investment trust’s stock valued at $95,000 after buying an additional 737 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.